Goldman Sachs Group Inc Alpha Teknova, Inc. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	BUY	$3.34 - $9.2 $1,015 - $2,796	304 Added 2.37%	13,110 $44,000
Q3 2022 Nov 10, 2022	BUY	$3.34 - $9.2 $1,015 - $2,796	304 Added 2.37%	13,110 $43,000
Q2 2022 May 14, 2024	BUY	$6.39 - $16.24 $81,830 - $207,969	12,806 New	12,806 $108,000
Q2 2022 Aug 15, 2022	BUY	$6.39 - $16.24 $14,562 - $37,010	2,279 Added 21.65%	12,806 $108,000
Q1 2022 May 16, 2022	BUY	$12.79 - $21.64 $134,640 - $227,804	10,527 New	10,527 $145,000
Q4 2021 Feb 14, 2022	SELL	$17.49 - $26.72 $594,047 - $907,544	-33,965 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$17.47 - $27.49 $593,368 - $933,697	33,965 New	33,965 $845,000

5.4M

Ticker TKNO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 28,080,500
Market Cap $202M
Description
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.